This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Genpharm International, Inc.. Active years: 2006-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2012
Title: Dianne M Fishwild: Innovator in Antibody Technology
Introduction
Dianne M Fishwild is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of three patents to her name, Fishwild's work has advanced the understanding and application of human sequence antibodies.
Latest Patents
One of her latest patents is focused on heterologous antibodies that bind human CD4. This invention relates to transgenic non-human animals capable of producing high affinity human sequence antibodies. The patent also addresses human sequence antibodies specific for human antigens, such as human CD4. Additionally, it outlines methods for producing these human sequence antibodies, showcasing her innovative approach to biotechnology.
Career Highlights
Dianne Fishwild has had a successful career, working with Genpharm International, Inc. Her expertise in antibody technology has positioned her as a leader in her field. She has been instrumental in advancing research that has the potential to impact therapeutic applications.
Collaborations
Throughout her career, Fishwild has collaborated with notable professionals in the industry, including Nils Lonberg and Robert M Kay. These collaborations have further enriched her work and contributed to the success of her inventions.
Conclusion
Dianne M Fishwild's contributions to antibody technology exemplify her innovative spirit and dedication to advancing biotechnology. Her patents and collaborations reflect her commitment to improving human health through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile